Showing 6,006 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Mental & emotional health problems

In HIV, Mental Health Impacts Viral Suppression, But Not Retention in Care

Editor's pick
Physician's Weekly
9 March 2023
Sexual health

Top 5 stories on sexual health from CROI 2023

News
9 March 2023
Weight gain & lipodystrophy

Weight gain on HIV treatment greater in people who start treatment with advanced HIV

News
9 March 2023
Injectable & long-acting HIV treatment

Rilpivirine resistance may be barrier to long-acting injectable treatment in South Africa

News
7 March 2023
Adherence

Rapid adherence testing sheds light on viral suppression and resistance

News
6 March 2023
HIV treatment

Lenacapavir (Sunlenca)

About HIV
March 2023
HIV treatment

Lenacapavir

About HIV
March 2023
Bad science & bogus treatments

No, Gammora HIV ‘cure kits’ not medically proven – stick to approved treatment

Editor's pick
Africa Check
1 March 2023
Injectable & long-acting HIV treatment

Lenacapavir plus broadly neutralising antibodies may offer twice-yearly treatment option

News
28 February 2023
Resistance

Failure of integrase inhibitor-based regimens may be due to a completely novel form of resistance

News
28 February 2023
Weight gain & lipodystrophy

Weight loss after treatment switch more likely for those with higher body mass

News
28 February 2023
New & experimental HIV treatments

White blood cell changes on islatravir do not lead to a higher risk of infections

News
28 February 2023
Treatment outcomes & life expectancy

Rates of Key Death Causes With HIV Falling in Europe/America

Editor's pick
NATAP
27 February 2023
Mental & emotional health & wellbeing

Combinations containing TAF and cobicistat linked to physical depression symptoms in women with HIV

News
23 February 2023
Injectable & long-acting HIV treatment

CROI 2023: Lenacapavir and two broadly neutralising antibodies for treatment Video

February 2023
Resistance

Treating HIV? Memorize These 12 HIV Resistance Mutations. Yes, Really.

Editor's pick
TheBodyPro
23 February 2023
New & experimental HIV treatments

Merck Opens Enrollment in New Phase 3 Clinical Trials with Investigational Once-Daily Islatravir in Combination with Doravirine for Treatment of HIV-1 Infection

Editor's pick
Merck press release
23 February 2023
Health problems in children & young people

Children's HIV Deaths in Africa Largely Preventable

Editor's pick
MedPage Today
23 February 2023
Injectable & long-acting HIV treatment

San Francisco shows that long-acting cabotegravir and rilpivirine may be feasible for people without viral suppression

News
23 February 2023
Injectable & long-acting HIV treatment

ViiV Healthcare announces positive data demonstrating long-acting injectable Cabenuva (cabotegravir, rilpivirine) is as effective as daily oral Biktarvy (BIC/FTC/TAF) for the treatment of HIV-1

Editor's pick
ViiV press release
23 February 2023
Weight gain & lipodystrophy

Switching to injectable cabotegravir and rilpivirine rarely affects body weight

News
23 February 2023
Access to healthcare

Sharing anti-HIV medication is common in rural Uganda

News
23 February 2023
Changing treatment

Dolutegravir plus darunavir superior to three-drug darunavir combination in second-line treatment

News
23 February 2023
Injectable & long-acting PrEP

Good news for women and PrEP: quarterly dosing may work

News
23 February 2023